Testing for H5N1 infection has been limited, and the outbreak was never confined. But asymptomatic cows in North Carolina may require a reassessment.
Category: Disease Rates
-
Person Infected With Bird Flu in Texas After Contact With Cattle
The case adds another worrying wrinkle to a global outbreak that has devastated bird and marine mammal populations, and recently appeared in cattle herds.
-
C.D.C. Shortens Isolation Period for People With Covid
Americans with Covid or other respiratory infections may return to daily activities if they don’t have a fever and their symptoms are improving.
-
Alcohol-Related Deaths Surge to Nearly 500 a Day, CDC Says
Spikes of fatalities linked to drinking that began with the Covid pandemic were not an anomaly. An estimated 178,000 people died in 2021 from similar causes.
-
Covid Closed the Nation’s Schools. Cleaner Air Can Keep Them Open.
Scientists and educators are searching for ways to improve air quality in the nation’s often dilapidated school buildings.
-
F.D.A. Outlines a Plan for Annual Covid Boosters
The New York Times – Business:In advance of a scientific meeting on Thursday, officials proposed offering new shots to Americans each fall, a strategy long employed against the flu.
-
China’s Looming ‘Tsunami’ of Covid Cases Will Test Its Hospitals
The New York Times – Business:To conserve resources for the severely ill, the government is urging residents not to seek help unless necessary. But the pivot has left many confused and anxious.
-
Outbreaks Test China’s Efforts to Limit the Cost of ‘Zero Covid’
The New York Times – Business:China wants to fine-tune its stringent pandemic restrictions to reduce the disruption to daily life caused by lockdowns. But officials are still taking few chances.
-
Will Covid Boosters Prevent Another Wave? Scientists Aren’t So Sure.
The New York Times – Business:The shots may help older, pregnant and immunocompromised Americans dodge serious illness or death. But the doses are not likely to prevent infections in any group, recent studies suggest.
-
Paxlovid May Reduce Risk of Long Covid in Eligible Patients, Study Finds
The New York Times – Business:The research looked at patients who qualified for the antiviral through age or health conditions. Those who took it shortly after infection were 26 percent less likely to have symptoms 90 days later.